NovaBridge Biosciences (FRA:0VY)
Germany · Delayed Price · Currency is EUR 2.180
-0.060 (-2.68%)
At close: Mar 27, 2026
NovaBridge Biosciences Market Cap
NovaBridge Biosciences has a market cap or net worth of €254.18 million as of March 27, 2026. Its market cap has increased by 303.87% in one year.
Market Cap
254.18M
Enterprise Value
58.89M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.18
Market Cap Chart
Since January 17, 2020, NovaBridge Biosciences's market cap has increased from 124.45M to 254.18M, an increase of 104.25%. That is a compound annual growth rate of 12.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 254.18M | -34.96% |
| Dec 31, 2025 | 390.81M | 484.53% |
| Dec 31, 2024 | 66.86M | -53.13% |
| Dec 29, 2023 | 142.66M | -56.11% |
| Dec 30, 2022 | 325.02M | -89.87% |
| Dec 31, 2021 | 3.21B | 18.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biotest Aktiengesellschaft | 1.41B |
| Darwin AG | 92.40M |
| 2invest AG | 62.87M |
| Biomark Diagnostics | 37.20M |
| co.don AG | 360.77K |
| bioXXmed AG | 323.52K |
| Paion AG | 231.13K |
| MagForce AG | 137.58K |